Related Experiment Video
Updated: Jun 25, 2026

Probing Myosin Ensemble Mechanics in Actin Filament Bundles Using Optical Tweezers
Published on: May 4, 2022
Cardiac myosin binding protein-C phosphorylation in a {beta}-myosin heavy chain background
Sakthivel Sadayappan1, James Gulick, Raisa Klevitsky
1Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Ohio, USA.
Background:
Cardiac myosin binding protein-C (cMyBP-C) phosphorylation modulates cardiac contractility. When expressed in cMyBP-C-null (cMyBP-C((t/t))) hearts, a cMyBP-C phosphomimetic (cMyBP-C(AllP+)) rescued cardiac dysfunction and protected the hearts from ischemia/reperfusion injury. However, cMyBP-C function may be dependent on the myosin isoform type. Because these replacements were performed in the mouse heart, which contains predominantly alpha-myosin heavy chain (alpha-MyHC), the applicability of the data to humans, whose cardiomyocytes contain predominantly beta-MyHC, is unclear. We determined the effect(s) of cMyBP-C phosphorylation in a beta-MyHC transgenic mouse heart in which >80% of the alpha-MyHC was replaced by beta-MyHC, which is the predominant myosin isoform in human cardiac muscle.
Methods And Results:
To determine the effects of cMyBP-C phosphorylation in a beta-MyHC background, transgenic mice expressing normal cMyBP-C (cMyBP-C(WT)), nonphosphorylatable cMyBP-C (cMyBP-C(AllP)(-)), or cMyBP-C(AllP+) were bred into the beta-MyHC background (beta). These mice were then crossed into the cMyBP-C((t/t)) background to ensure the absence of endogenous cMyBP-C. cMyBP-C((t/t)/beta) and cMyBP-C(AllP)(-)(:(t/t)/beta) mice died prematurely because of heart failure, confirming that cMyBP-C phosphorylation is essential in the beta-MyHC background. cMyBP-C(AllP+:(t/t)/beta) and cMyBP-C(WT:(t/t)/beta) hearts showed no morbidity and mortality, and cMyBP-C(AllP+:(t/t)/beta) hearts were significantly cardioprotected from ischemia/reperfusion injury.
Conclusions:
cMyBP-C phosphorylation is necessary for basal myocardial function in the beta-MyHC background and can preserve function after ischemia/reperfusion injury. Our studies justify exploration of cMyBP-C phosphorylation as a therapeutic target in the human heart.
Insights
Cardiac myosin binding protein-C (cMyBP-C) phosphorylation is essential for normal heart function in a beta-myosin heavy chain (beta-MyHC) environment. This phosphorylation also protects the heart from ischemia/reperfusion injury, suggesting therapeutic potential.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Cardiac Muscle Physiology
Background:
- Cardiac myosin binding protein-C (cMyBP-C) phosphorylation is a key regulator of cardiac contractility.
- Previous studies in alpha-myosin heavy chain (alpha-MyHC) hearts showed cMyBP-C phosphomimetics rescued cardiac dysfunction.
- The relevance to human hearts, which predominantly express beta-myosin heavy chain (beta-MyHC), remained unclear.
Purpose of the Study:
- To investigate the role of cMyBP-C phosphorylation in a beta-MyHC background.
- To determine if cMyBP-C phosphorylation is essential for cardiac function in beta-MyHC hearts.
- To assess the cardioprotective effects of cMyBP-C phosphorylation against ischemia/reperfusion injury in a beta-MyHC context.
Main Methods:
- Generated transgenic mice expressing different forms of cMyBP-C (WT, nonphosphorylatable, phosphomimetic) in a beta-MyHC background.
- Crossed these mice into a cMyBP-C-null background to eliminate endogenous cMyBP-C.
- Assessed cardiac function, survival, and response to ischemia/reperfusion injury.
Main Results:
- Mice lacking functional cMyBP-C phosphorylation in the beta-MyHC background (cMyBP-C(AllP)(-):(t/t)/beta) exhibited premature death due to heart failure.
- Hearts expressing phosphomimetic or wild-type cMyBP-C in the beta-MyHC background showed no significant morbidity or mortality.
- Phosphomimetic cMyBP-C significantly protected these hearts from ischemia/reperfusion injury.
Conclusions:
- cMyBP-C phosphorylation is critical for maintaining basal myocardial function in the beta-MyHC environment.
- cMyBP-C phosphorylation confers significant protection against ischemia/reperfusion injury in the human-relevant beta-MyHC background.
- Targeting cMyBP-C phosphorylation represents a promising therapeutic strategy for human heart conditions.
Related Concept Videos
Overview of Myosin Structure and Function
Actin and Myosin in Muscle Contraction
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Cross-bridge Cycle
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Smooth Muscle Contraction
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
